1. Home
  2. DDI vs NBY Comparison

DDI vs NBY Comparison

Compare DDI & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DoubleDown Interactive Co. Ltd. American Depository Shares

DDI

DoubleDown Interactive Co. Ltd. American Depository Shares

HOLD

Current Price

$8.95

Market Cap

433.6M

Sector

Technology

ML Signal

HOLD

Logo NovaBay Pharmaceuticals Inc.

NBY

NovaBay Pharmaceuticals Inc.

HOLD

Current Price

$1.38

Market Cap

31.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
DDI
NBY
Founded
2008
2000
Country
South Korea
United States
Employees
N/A
N/A
Industry
EDP Services
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
433.6M
31.6M
IPO Year
2020
2007

Fundamental Metrics

Financial Performance
Metric
DDI
NBY
Price
$8.95
$1.38
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$19.00
N/A
AVG Volume (30 Days)
57.3K
917.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
35.42
EPS
N/A
0.76
Revenue
N/A
$370,000.00
Revenue This Year
$6.65
$23.91
Revenue Next Year
$2.64
$32.05
P/E Ratio
$4.31
$1.87
Revenue Growth
N/A
N/A
52 Week Low
$8.09
$0.43
52 Week High
$11.25
$19.95

Technical Indicators

Market Signals
Indicator
DDI
NBY
Relative Strength Index (RSI) 48.51 44.87
Support Level $8.64 $0.99
Resistance Level $9.32 $2.52
Average True Range (ATR) 0.35 0.22
MACD -0.04 0.15
Stochastic Oscillator 40.22 36.49

Price Performance

Historical Comparison
DDI
NBY

About DDI DoubleDown Interactive Co. Ltd. American Depository Shares

DoubleDown Interactive Co Ltd is a developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players. The company's operating segments include the social casino games segment and the iGaming segment. The company generates the majority of its revenue from social casino games. Geographically, the company generates the majority of its revenue from the United States.

About NBY NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Share on Social Networks: